All-Cause Gastroenteritis and Rotavirus-Coded Hospitalizations Among US Children, 2000–2009

Desai, Rishi; Curns, Aaron T.; Steiner, Claudia A.; Tate, Jacqueline E.; Patel, Manish M.; Parashar, Umesh D.
August 2012
Clinical Infectious Diseases;8/15/2012, Vol. 55 Issue 4, pe28
Academic Journal
Since the approval of rotavirus vaccine in 2006 for routine use in US children, there has been a marked reduction in the number of and direct medical charges for all-cause gastroenteritis hospitalizations and rotavirus-coded hospitalizations.Background. Rotavirus vaccine was recommended for US infants in 2006. We estimated baseline prevaccine burden and monitored postvaccine trends in gastroenteritis-coded and rotavirus-coded hospitalizations among US children.Methods. We analyzed data from the State Inpatient Databases (SID) for 29–44 US states over a 10-year period (2000–2009) to calculate gastroenteritis and rotavirus-coded hospitalization rates by age group, sex, and region, among children <5 years of age. By extrapolating observed pre- and postvaccine gastroenteritis hospitalization rates to the US population <5 years and based on the 2009 cost of a diarrhea hospitalization, we estimated national reductions in diarrhea hospitalizations and associated treatment costs.Results. The prevaccine (2000–2006) annual average gastroenteritis-coded hospitalization rate among children <5 years of age was 74 per 10 000 (annual range, 71–82 per 10 000), and declined to 51 and 50 per 10 000 in 2008 and 2009, respectively (P < .001). The prevaccine (2000–2006) annual average rotavirus-coded hospitalization rate among children <5 years of age was 15 per 10 000 (annual range, 13–18 per 10 000), and declined to 5 and 6 per 10 000 in 2008 and 2009, respectively (P < .001). The decreases in rotavirus-coded hospitalization rates in 2008 and 2009 compared with rates in prevaccine years were observed among all age groups and US regions. Nationally, during 2008 and 2009 combined, we estimated a reduction of approximately 77 000 diarrhea hospitalizations and approximately $242 million in hospital costs.Conclusions. Since implementation of the US rotavirus vaccination program, a marked reduction in diarrhea hospitalizations and related hospital charges has occurred among US children.


Related Articles

  • Intussusception rate not increased by rotavirus vaccine in US.  // Reactions Weekly;2/4/2012, Issue 1387, p3 

    The article reports that reintroduction of the rotavirus vaccine in the U.S. since 2006 has not resulted in any increase in the rate of hospital discharges for intussusception.

  • The Dominican Republic Introduces Rotavirus Vaccine into National Immunization Schedule.  // Immunization Newsletter;Aug2012, Vol. 34 Issue 4, p4 

    The article reports on the introduction of rotavirus vaccine by the Dominican Republic on July 4, 2012 into its national immunization schedule for preventing diarrhea in children and avoid mortality.

  • New rotavirus vaccine for diarrhoea reaches Rwanda.  // Africa Health;Jul2012, Vol. 34 Issue 5, p11 

    The article reports that Rwanda is the latest among the growing number of African countries to receive the rotavirus vaccine for children against diarrhea.

  • Rotavirus genotypes associated with childhood severe acute diarrhoea in southern Ghana: a cross-sectional study. Enweronu-Laryea, Christabel C.; Sagoe, Kwamena W.; Damanka, Susan; Lartey, Belinda; Armah, George E. // Virology Journal;2013, Vol. 10 Issue 1, p1 

    Background: Rotavirus immunization has been effective in developed countries where genotype G1P[8] is the predominant rotavirus strain. Knowledge of circulating strains in a population before introduction of rotavirus immunization program will be useful in evaluating the effect of the...

  • Epidemiology and prospects for prevention of rotavirus disease in India. Kahn, G.; Fitzwater, S.; Tate, J.; Kang, G.; Ganguly, N.; Nair, G.; Steele, D.; Arora, R.; Chawlasarkar, M.; Parashar, U.; Santosham, M. // Indian Pediatrics;Jun2012, Vol. 49 Issue 6, p467 

    Context: With rotavirus vaccines now available globally, it will be useful to assemble the available evidence on the epidemiology and burden of rotavirus gastroenteritis in India, in order to weigh the urgency of introducing a vaccine to help control rotavirus disease. Evidence Acquisition: We...

  • High Incidence of Staphylococcus aureus and Norovirus Gastroenteritis in Infancy: A Single-Center, 1-Year Experience. Kyoung Sung; Ji Yong Kim; Yeoun Joo Lee; Eun Ha Hwang; Jae Hong Park // Pediatric Gastroenterology, Hepatology & Nutrition;Sep2014, Vol. 17 Issue 3, p140 

    Purpose: The etiology of acute gastroenteritis (AGE) has changed since the introduction of the rotavirus vaccination. The aim of this study was to clarify which common pathogens, both bacterial and viral, are currently causing AGE in infants. Methods: Infants with acute diarrhea were enrolled....

  • Childhood Diarrhea Deaths after Rotavirus Vaccination in Mexico. Richardson, Vesta; Parashar, Umesh; Patel, Manish // New England Journal of Medicine;8/25/2011, Vol. 365 Issue 8, p772 

    A letter to the editor is presented about the reduction in diarrhea-related deaths in children after the introduction of rotavirus vaccination in Mexico.

  • Gastroenteritis por rotavirus en lactantes previamente inmunizados. Gómez, Ulises Reyes; Ponce, Bárbara Ramírez; Hernández, Ulises Reyes; Lira, Idalia Hernández; Hernández, Diana Reyes; Robles, Antelma Martínez // Revista de Enfermedades Infecciosas en Pediatria;jul-sep2009, Vol. 23 Issue 89, p8 

    We report 10 infants attended in Oaxaca City during november 2008 to january 2009, who presented diarrhea due to rotavirus. All of them had received two doses of rotavirus vaccine by the national system of health. The mean age was 8 months, nine of them initiated with alimentary vomits, followed...

  • Investigation of Stilbenoids as Potential Therapeutic Agents for Rotavirus Gastroenteritis. Ball, Judith M.; Medina-Bolivar, Fabricio; Defrates, Katelyn; Hambleton, Emily; Hurlburt, Megan E.; Fang, Lingling; Yang, Tianhong; Nopo-Olazabal, Luis; Atwill, Richard L.; Ghai, Pooja; Parr, Rebecca D. // Advances in Virology;8/26/2015, Vol. 2015, p1 

    Rotavirus (RV) infections cause severe diarrhea in infants and young children worldwide. Vaccines are available but cost prohibitive for many countries and only reduce severe symptoms. Vaccinated infants continue to shed infectious particles, and studies show decreased efficacy of the RV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics